Drug Information

Drug General Information
Drug ID
D0PU1J
Former ID
DNC000365
Drug Name
BW B218C
Drug Type
Small molecular drug
Indication Discovery agent Investigative [536518]
Structure
Download
2D MOL

3D MOL
Formula
C18H19NO3
Canonical SMILES
CC(C=CC1=CC(=CC=C1)OC2=CC=CC=C2)N(C(=O)C)O
InChI
1S/C18H19NO3/c1-14(19(21)15(2)20)11-12-16-7-6-10-18(13-16)22-17-8-4-3-5-9-17/h3-14,21H,1-2H3/b12-11+
InChIKey
ZLIVOFMPDUIULQ-VAWYXSNFSA-N
CAS Number
CAS 134470-36-3
PubChem Compound ID
6439376
PubChem Substance ID
11968281, 15419278, 43032308, 77213526, 114558518, 134339809, 135087084, 138390110, 224927530, 231773275
Target and Pathway
Target(s) Arachidonate 5-lipoxygenase Target Info Inhibitor [536518]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Vitamin D Receptor Pathway
Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 536518Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99.
Ref 536518Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.